Publicaciones en colaboración con investigadores/as de Maastricht University Medical Centre (2)

2021

  1. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: The results of the AFFIRM-AHF study

    European Heart Journal, Vol. 42, Núm. 31, pp. 3011-3020

2020

  1. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

    The Lancet, Vol. 396, Núm. 10266, pp. 1895-1904